Beverages - Alcoholic
Compare Stocks
5 / 10Stock Comparison
TAP vs BUD vs SAM vs STZ vs BG
Revenue, margins, valuation, and 5-year total return — side by side.
Beverages - Alcoholic
Beverages - Alcoholic
Beverages - Wineries & Distilleries
Agricultural Farm Products
TAP vs BUD vs SAM vs STZ vs BG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Beverages - Alcoholic | Beverages - Alcoholic | Beverages - Alcoholic | Beverages - Wineries & Distilleries | Agricultural Farm Products |
| Market Cap | $8.10B | $138.11B | $2.18B | $26.05B | $24.02B |
| Revenue (TTM) | $11.19B | $119.82B | $2.09B | $9.38B | $80.54B |
| Net Income (TTM) | $-2.11B | $12.57B | $-61M | $1.11B | $686M |
| Gross Margin | 37.8% | 55.2% | 45.2% | 52.0% | 5.2% |
| Operating Margin | -20.3% | 31.7% | -3.8% | 34.5% | 2.4% |
| Forward P/E | 9.2x | 18.8x | 20.6x | 12.7x | 14.4x |
| Total Debt | $6.30B | $72.17B | $38M | $12.11B | $16.95B |
| Cash & Equiv. | $897M | $11.17B | $223M | $68M | $1.14B |
TAP vs BUD vs SAM vs STZ vs BG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Molson Coors Bevera… (TAP) | 100 | 113.6 | +13.6% |
| Anheuser-Busch InBe… (BUD) | 100 | 171.2 | +71.2% |
| The Boston Beer Com… (SAM) | 100 | 35.9 | -64.1% |
| Constellation Brand… (STZ) | 100 | 87.0 | -13.0% |
| Bunge Global S.A. (BG) | 100 | 317.3 | +217.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TAP vs BUD vs SAM vs STZ vs BG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TAP is the #2 pick in this set and the best alternative if value and dividends is your priority.
- Lower P/E (9.2x vs 14.4x)
- 4.5% yield, 5-year raise streak, vs BUD's 1.6%, (1 stock pays no dividend)
BUD ranks third and is worth considering specifically for efficiency.
- 6.0% ROA vs TAP's -8.9%, ROIC 7.5% vs -10.1%
Among these 5 stocks, SAM doesn't own a clear edge in any measured category.
STZ is the clearest fit if your priority is quality.
- 11.8% margin vs TAP's -18.9%
BG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.25, yield 2.2%
- Rev growth 32.4%, EPS growth -38.4%, 3Y rev CAGR 1.5%
- 140.3% 10Y total return vs BUD's -24.5%
- Lower volatility, beta 0.25, Low D/E 97.3%, current ratio 1.61x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.4% revenue growth vs TAP's -4.2% | |
| Value | Lower P/E (9.2x vs 14.4x) | |
| Quality / Margins | 11.8% margin vs TAP's -18.9% | |
| Stability / Safety | Beta 0.25 vs SAM's 0.29 | |
| Dividends | 4.5% yield, 5-year raise streak, vs BUD's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.8% vs TAP's -20.8% | |
| Efficiency (ROA) | 6.0% ROA vs TAP's -8.9%, ROIC 7.5% vs -10.1% |
TAP vs BUD vs SAM vs STZ vs BG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
TAP vs BUD vs SAM vs STZ vs BG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TAP leads in 2 of 6 categories
SAM leads 1 • BG leads 1 • BUD leads 0 • STZ leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BUD and STZ each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BUD is the larger business by revenue, generating $119.8B annually — 57.2x SAM's $2.1B. STZ is the more profitable business, keeping 11.8% of every revenue dollar as net income compared to TAP's -18.9%. On growth, BG holds the edge at +87.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $11.2B | $119.8B | $2.1B | $9.4B | $80.5B |
| EBITDAEarnings before interest/tax | -$1.5B | $38.8B | $14M | $3.7B | $2.8B |
| Net IncomeAfter-tax profit | -$2.1B | $12.6B | -$61M | $1.1B | $686M |
| Free Cash FlowCash after capex | $1.2B | $32.2B | $191M | $1.8B | $112M |
| Gross MarginGross profit ÷ Revenue | +37.8% | +55.2% | +45.2% | +52.0% | +5.2% |
| Operating MarginEBIT ÷ Revenue | -20.3% | +31.7% | -3.8% | +34.5% | +2.4% |
| Net MarginNet income ÷ Revenue | -18.9% | +10.5% | -2.9% | +11.8% | +0.9% |
| FCF MarginFCF ÷ Revenue | +10.4% | +26.9% | +9.1% | +18.8% | +0.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +0.4% | +1.7% | -9.8% | +87.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +35.6% | +32.3% | -7.4% | -15.0% | -76.4% |
Valuation Metrics
TAP leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 20.5x trailing earnings, SAM trades at a 27% valuation discount to BUD's 28.1x P/E. On an enterprise value basis, SAM's 8.5x EV/EBITDA is more attractive than BG's 22.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.1B | $138.1B | $2.2B | $26.1B | $24.0B |
| Enterprise ValueMkt cap + debt − cash | $13.5B | $199.1B | $2.0B | $38.1B | $39.8B |
| Trailing P/EPrice ÷ TTM EPS | -3.98x | 28.06x | 20.50x | -333.89x | 25.16x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.17x | 18.81x | 20.56x | 12.70x | 14.38x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 9.47x | 8.45x | 9.37x | 22.60x |
| Price / SalesMarket cap ÷ Revenue | 0.73x | 2.31x | 1.04x | 2.55x | 0.34x |
| Price / BookPrice ÷ Book value/share | 0.80x | 1.85x | 2.54x | 3.82x | 1.18x |
| Price / FCFMarket cap ÷ FCF | 7.58x | 12.34x | 10.09x | 13.44x | — |
Profitability & Efficiency
SAM leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
STZ delivers a 13.9% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-19 for TAP. SAM carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to STZ's 1.70x. On the Piotroski fundamental quality scale (0–9), BUD scores 9/9 vs BG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -18.6% | +13.8% | -7.3% | +13.9% | +4.3% |
| ROA (TTM)Return on assets | -8.9% | +6.0% | -5.0% | +5.1% | +1.6% |
| ROICReturn on invested capital | -10.1% | +7.5% | +15.5% | +13.0% | +3.3% |
| ROCEReturn on capital employed | -11.6% | +8.7% | +14.8% | +18.0% | +4.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 9 | 7 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.60x | 0.81x | 0.04x | 1.70x | 0.97x |
| Net DebtTotal debt minus cash | $5.4B | $61.0B | -$186M | $12.0B | $15.8B |
| Cash & Equiv.Liquid assets | $897M | $11.2B | $223M | $68M | $1.1B |
| Total DebtShort + long-term debt | $6.3B | $72.2B | $38M | $12.1B | $17.0B |
| Interest CoverageEBIT ÷ Interest expense | -9.99x | 2.53x | — | 5.47x | 3.10x |
Total Returns (Dividends Reinvested)
BG leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BG five years ago would be worth $14,937 today (with dividends reinvested), compared to $1,818 for SAM. Over the past 12 months, BG leads with a +66.8% total return vs TAP's -20.8%. The 3-year compound annual growth rate (CAGR) favors BG at 13.5% vs SAM's -13.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.0% | +26.0% | +1.5% | +7.9% | +34.4% |
| 1-Year ReturnPast 12 months | -20.8% | +24.5% | -15.9% | -18.7% | +66.8% |
| 3-Year ReturnCumulative with dividends | -24.8% | +27.5% | -35.0% | -29.0% | +46.3% |
| 5-Year ReturnCumulative with dividends | -14.1% | +12.4% | -81.8% | -30.1% | +49.4% |
| 10-Year ReturnCumulative with dividends | -41.4% | -24.5% | +32.0% | +12.6% | +140.3% |
| CAGR (3Y)Annualised 3-year return | -9.1% | +8.4% | -13.4% | -10.8% | +13.5% |
Risk & Volatility
Evenly matched — TAP and BUD each lead in 1 of 2 comparable metrics.
Risk & Volatility
TAP is the less volatile stock with a -0.01 beta — it tends to amplify market swings less than SAM's 0.29 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BUD currently trades 96.8% from its 52-week high vs TAP's 74.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.01x | 0.28x | 0.29x | 0.26x | 0.25x |
| 52-Week HighHighest price in past year | $57.57 | $82.91 | $264.46 | $196.91 | $133.93 |
| 52-Week LowLowest price in past year | $40.64 | $56.97 | $185.34 | $126.45 | $71.60 |
| % of 52W HighCurrent price vs 52-week peak | +74.9% | +96.8% | +76.7% | +76.3% | +92.4% |
| RSI (14)Momentum oscillator 0–100 | 47.2 | 70.7 | 28.7 | 45.9 | 51.8 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 2.0M | 199K | 1.8M | 1.7M |
Analyst Outlook
TAP leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TAP as "Hold", BUD as "Buy", SAM as "Hold", STZ as "Buy", BG as "Buy". Consensus price targets imply 21.7% upside for SAM (target: $247) vs 8.0% for BG (target: $134). For income investors, TAP offers the higher dividend yield at 4.46% vs BUD's 1.63%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $48.30 | $89.00 | $246.86 | $175.70 | $133.67 |
| # AnalystsCovering analysts | 37 | 45 | 31 | 46 | 25 |
| Dividend YieldAnnual dividend ÷ price | +4.5% | +1.6% | — | +2.7% | +2.2% |
| Dividend StreakConsecutive years of raises | 5 | 0 | 0 | 4 | 5 |
| Dividend / ShareAnnual DPS | $1.92 | $1.31 | — | $4.03 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +8.0% | +0.7% | +9.4% | +4.3% | +2.3% |
TAP leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). SAM leads in 1 (Profitability & Efficiency). 2 tied.
TAP vs BUD vs SAM vs STZ vs BG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TAP or BUD or SAM or STZ or BG a better buy right now?
For growth investors, Bunge Global S.
A. (BG) is the stronger pick with 32. 4% revenue growth year-over-year, versus -4. 2% for Molson Coors Beverage Company (TAP). The Boston Beer Company, Inc. (SAM) offers the better valuation at 20. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Anheuser-Busch InBev SA/NV (BUD) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TAP or BUD or SAM or STZ or BG?
On trailing P/E, The Boston Beer Company, Inc.
(SAM) is the cheapest at 20. 5x versus Anheuser-Busch InBev SA/NV at 28. 1x. On forward P/E, Molson Coors Beverage Company is actually cheaper at 9. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TAP or BUD or SAM or STZ or BG?
Over the past 5 years, Bunge Global S.
A. (BG) delivered a total return of +49. 4%, compared to -81. 8% for The Boston Beer Company, Inc. (SAM). Over 10 years, the gap is even starker: BG returned +140. 3% versus TAP's -41. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TAP or BUD or SAM or STZ or BG?
By beta (market sensitivity over 5 years), Molson Coors Beverage Company (TAP) is the lower-risk stock at -0.
01β versus The Boston Beer Company, Inc. 's 0. 29β — meaning SAM is approximately -2517% more volatile than TAP relative to the S&P 500. On balance sheet safety, The Boston Beer Company, Inc. (SAM) carries a lower debt/equity ratio of 4% versus 170% for Constellation Brands, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TAP or BUD or SAM or STZ or BG?
By revenue growth (latest reported year), Bunge Global S.
A. (BG) is pulling ahead at 32. 4% versus -4. 2% for Molson Coors Beverage Company (TAP). On earnings-per-share growth, the picture is similar: The Boston Beer Company, Inc. grew EPS 95. 5% year-over-year, compared to -302. 8% for Molson Coors Beverage Company. Over a 3-year CAGR, STZ leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TAP or BUD or SAM or STZ or BG?
Anheuser-Busch InBev SA/NV (BUD) is the more profitable company, earning 9.
8% net margin versus -19. 2% for Molson Coors Beverage Company — meaning it keeps 9. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: STZ leads at 35. 5% versus -21. 0% for TAP. At the gross margin level — before operating expenses — BUD leads at 55. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TAP or BUD or SAM or STZ or BG more undervalued right now?
On forward earnings alone, Molson Coors Beverage Company (TAP) trades at 9.
2x forward P/E versus 20. 6x for The Boston Beer Company, Inc. — 11. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SAM: 21. 7% to $246. 86.
08Which pays a better dividend — TAP or BUD or SAM or STZ or BG?
In this comparison, TAP (4.
5% yield), STZ (2. 7% yield), BG (2. 2% yield), BUD (1. 6% yield) pay a dividend. SAM does not pay a meaningful dividend and should not be held primarily for income.
09Is TAP or BUD or SAM or STZ or BG better for a retirement portfolio?
For long-horizon retirement investors, Molson Coors Beverage Company (TAP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
01), 4. 5% yield). Both have compounded well over 10 years (TAP: -41. 4%, SAM: +32. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TAP and BUD and SAM and STZ and BG?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TAP is a small-cap income-oriented stock; BUD is a mid-cap quality compounder stock; SAM is a small-cap quality compounder stock; STZ is a mid-cap quality compounder stock; BG is a mid-cap high-growth stock. TAP, BUD, STZ, BG pay a dividend while SAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 43%
- Dividend Yield > 0.8%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.